General form of registration statement for all companies including face-amount certificate companies

Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Dilutive Common Stock Equivalents (Details) (10-K) (Parenthetical)

v3.21.1
Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Dilutive Common Stock Equivalents (Details) (10-K) (Parenthetical) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Common stock issuable upon conversion, shares 4,368,486 7,936,740  
Common stock issuable upon conversion $ 1,186,176 $ 793,674  
Beneficial ownership limitations percentage 4.99% 4.99%  
Convertible Notes Payable One [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Common stock issuable upon conversion, shares     6,227,340
Common stock issuable upon conversion     $ 1,294,268
Beneficial ownership limitations percentage     4.99%